Loeb & Loeb is pleased to announce that Food & Drug Administration partners Scott Liebman and Jim Czaban and Patent Litigation partner Mark Waddell were recognized in the 2021 edition of the LMG Life Sciences rankings, a definitive guide to lawyers and law firms that specialize in the life sciences industry. In addition, the firm was shortlisted in the “Regulatory Firm to Watch” award category at the 2021 LMG Life Sciences Americas Awards.
The rankings highlight firms and lawyers that specialize in four main practice areas: regulatory, intellectual property, financial and corporate, and non-IP litigation and enforcement.
Specifically, Liebman and Czaban were both recognized in the FDA: Medical Device and FDA: Pharmaceutical categories, while Waddell was recognized in the Patent Strategy & Management category.
This year’s ninth annual LMG Life Sciences Americas Awards ceremony was held on September 22, 2021 in New York.
For more information, please visit LMG Life Sciences’ website.